Fredrick D. Ashbury
Gründer bei Viviphi Ltd.
Aktive Positionen von Fredrick D. Ashbury
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Viviphi Ltd.
 Viviphi Ltd. Packaged SoftwareTechnology Services Viviphi Ltd., also known as VieCure, is an artificial intelligence platform that has developed a proprietary informatics software platform in conjunction with a clinical inference engine and point-of-care decision support system in oncology. The company is based in Denver, CO. The platform combines the latest in clinical knowledge with patient data to assist clinicians in generating personalized treatment plans and better managing a patient’s treatment throughout diagnosis, cancer therapy, and ongoing follow-up care. The company was founded by Fredrick D. Ashbury, Gerald Hogue. Gerald Hogue has been the CEO since incorporation. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
| Gründer | - | - |
Karriereverlauf von Fredrick D. Ashbury
Ehemalige bekannte Positionen von Fredrick D. Ashbury
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| York University | Corporate Officer/Principal | - | - |
| University of Manitoba | Corporate Officer/Principal | - | - |
| University of Toronto | Corporate Officer/Principal | - | - |
| McGill University | Corporate Officer/Principal | - | - |
OpTx Corp.
 OpTx Corp. Packaged SoftwareTechnology Services Part of Siemens AG, OpTx Corp. is a company that provides oncology-specific software and services providers. The company is based in Englewood, CO. OpTx was acquired by Varian Medical Systems, Inc., part of Siemens AG from April 15, 2021 on March 29, 2004 for $18 million. The company was founded by Gerald Hogue. | Corporate Officer/Principal | - | - |
BridgeSite Clinical Research, Inc.
 BridgeSite Clinical Research, Inc. Medical/Nursing ServicesHealth Services Bridgesite Clinical Research, Inc. engages in the provision of clinical research services. The company was founded by Thomas J. Baxter and is headquartered in Columbus, OH. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Fredrick D. Ashbury
| Queen's University | Graduate Degree |
| University of Toronto | Undergraduate Degree |
| The University of York | Doctorate Degree |
Statistik
International
| Kanada | 6 |
| Vereinigte Staaten | 4 |
| Vereinigtes Königreich | 2 |
Operativ
| Corporate Officer/Principal | 5 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Consumer Services | 7 |
| Technology Services | 3 |
| Health Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
OpTx Corp.
OpTx Corp. Packaged SoftwareTechnology Services Part of Siemens AG, OpTx Corp. is a company that provides oncology-specific software and services providers. The company is based in Englewood, CO. OpTx was acquired by Varian Medical Systems, Inc., part of Siemens AG from April 15, 2021 on March 29, 2004 for $18 million. The company was founded by Gerald Hogue. | Technology Services |
BridgeSite Clinical Research, Inc.
BridgeSite Clinical Research, Inc. Medical/Nursing ServicesHealth Services Bridgesite Clinical Research, Inc. engages in the provision of clinical research services. The company was founded by Thomas J. Baxter and is headquartered in Columbus, OH. | Health Services |
Viviphi Ltd.
Viviphi Ltd. Packaged SoftwareTechnology Services Viviphi Ltd., also known as VieCure, is an artificial intelligence platform that has developed a proprietary informatics software platform in conjunction with a clinical inference engine and point-of-care decision support system in oncology. The company is based in Denver, CO. The platform combines the latest in clinical knowledge with patient data to assist clinicians in generating personalized treatment plans and better managing a patient’s treatment throughout diagnosis, cancer therapy, and ongoing follow-up care. The company was founded by Fredrick D. Ashbury, Gerald Hogue. Gerald Hogue has been the CEO since incorporation. | Technology Services |
- Börse
- Insiders
- Fredrick D. Ashbury
- Erfahrung